Skip to main content

DAFNA Capital Management LLC

Position in FATE — Fate Therapeutics Inc

CIK 1389933 LOS ANGELES, CA

Position in FATE

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$660,000
+$121,000 QoQ
Shares Held
550,000
0.0% QoQ
Ownership
0.472%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in FATE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DAFNA Capital Management LLC holds $266,800,868 across 59 Biotechnology names. FATE ranks #46 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FATE

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $660,000 550,000
2025-12-31 $539,000 550,000
2022-12-31 $5,558,984 550,940
2022-09-30 $12,100,055 539,940
2022-06-30 $13,652,293 550,940
2022-03-31 $19,421,056 500,930
2021-12-31 $21,775,081 372,160
2021-09-30 $20,410,217 344,360
2021-06-30 $27,283,304 314,360
2021-03-31 $25,918,982 314,360
2020-12-31 $30,403,354 334,360
2020-09-30 $17,525,246 438,460
2020-06-30 $16,841,440 490,861
2020-03-31 $10,438,700 470,000